These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32694738)

  • 1. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.
    Golforoush PA; Narasimhan P; Chaves-Guerrero PP; Lawrence E; Newton G; Yan R; Harding SE; Perrior T; Chapman KL; Schneider MD
    Sci Rep; 2020 Jul; 10(1):12060. PubMed ID: 32694738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
    Fiedler LR; Chapman K; Xie M; Maifoshie E; Jenkins M; Golforoush PA; Bellahcene M; Noseda M; Faust D; Jarvis A; Newton G; Paiva MA; Harada M; Stuckey DJ; Song W; Habib J; Narasimhan P; Aqil R; Sanmugalingam D; Yan R; Pavanello L; Sano M; Wang SC; Sampson RD; Kanayaganam S; Taffet GE; Michael LH; Entman ML; Tan TH; Harding SE; Low CMR; Tralau-Stewart C; Perrior T; Schneider MD
    Cell Stem Cell; 2019 Apr; 24(4):579-591.e12. PubMed ID: 30853557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.
    Nemade H; Chaudhari U; Acharya A; Hescheler J; Hengstler JG; Papadopoulos S; Sachinidis A
    Arch Toxicol; 2018 Apr; 92(4):1507-1524. PubMed ID: 29397400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?
    Te Lintel Hekkert M; Newton G; Chapman K; Aqil R; Downham R; Yan R; Merkus D; Whitlock G; Lane CAL; Cawkill D; Perrior T; Duncker DJ; Schneider MD
    Basic Res Cardiol; 2021 May; 116(1):34. PubMed ID: 34018053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling.
    Hsu WT; Huang CY; Yen CYT; Cheng AL; Hsieh PCH
    Theranostics; 2018; 8(12):3176-3188. PubMed ID: 29930721
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
    Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
    Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.
    Ludke A; Sharma AK; Bagchi AK; Singal PK
    Mol Cell Biochem; 2012 Jan; 360(1-2):215-24. PubMed ID: 21938406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling cadmium-induced cardiotoxicity using human pluripotent stem cell-derived cardiomyocytes.
    Shen J; Wang X; Zhou D; Li T; Tang L; Gong T; Su J; Liang P
    J Cell Mol Med; 2018 Sep; 22(9):4221-4235. PubMed ID: 29993192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
    Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
    Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
    Bozza WP; Takeda K; Alterovitz WL; Chou CK; Shen RF; Zhang B
    AAPS J; 2021 Mar; 23(2):44. PubMed ID: 33719006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
    Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
    J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase inhibitor-induced cardiotoxicity assessed in vitro with human pluripotent stem cell derived cardiomyocytes.
    Xian HQ; Blanco C; Bonham K; Snodgrass HR
    Toxicol Appl Pharmacol; 2022 Feb; 437():115886. PubMed ID: 35041852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy.
    Berecz T; Yiu A; Vittay O; Orsolits B; Mioulane M; Dos Remedios CG; Ketteler R; Merkely B; Apáti Á; Harding SE; Hellen N; Foldes G
    ESC Heart Fail; 2022 Feb; 9(1):224-235. PubMed ID: 34931757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin.
    Koczurkiewicz-Adamczyk P; Klaś K; Gunia-Krzyżak A; Piska K; Andrysiak K; Stępniewski J; Lasota S; Wójcik-Pszczoła K; Dulak J; Madeja Z; Pękala E
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.